The last thing a parent wants to do when their child is not feeling well is to make them wait for relief. Now, thanks to an innovative new product, DocuSol® Kids, caregivers can help young ones with constipation not only feel better faster, but avoid further complications associated with not being able to have a bowel movement.
Constipation is a serious medical issue. Research shows that adolescents with chronic constipation have a worse quality of life than those with more serious medical conditions such as inflammatory bowel disease and gastro-esophageal reflux disease. Constipation affects 25 to 30% of young children which means approximately one in three children will struggle with this condition. Constipation also increases the risk of urinary tract infections.
Since 2008, researchers have found that the number of constipated children seen by primary care doctors has nearly doubled in the past decade. Caring for children with constipation is also expensive with associated healthcare costs reaching an estimated $3.9 billion a year.
Alliance Labs is pleased to announce, the first-of-its kind formulation DocuSol® Kids. DocuSol® Kids is a 5ml mini-enema delivering 100mg of docusate sodium in a polyethylene glycol base. Docusol Kids is approved for children 2-12 years of age. Patients can count on DocuSol® Kids to provide fast, predictable results typically within 2-15 minutes. Docusol® Kids is an easy rectal therapy for those children unwilling to swallow medications. Parents can receive additional information on where DocuSol® Kids can be purchased, more on how it works or request a free sample at www.docusolkids.com.